<DOC>
	<DOCNO>NCT00530517</DOCNO>
	<brief_summary>Intraject needle-free , single use , disposable , subcutaneous delivery system pre-filled 6mg Sumatriptan use patient treat acute migraine treatment . Study participation last one month include 2 doctor visit 2-4 phone call .</brief_summary>
	<brief_title>A Study Usability Needle-Free Intraject® System Adult Patients During Acute Migraine Attack</brief_title>
	<detailed_description>This study evaluate patient interact needle-free Intraject system actual self-administration abdomen thigh treatment migraine headache outside clinic .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>Have diagnosis migraine average ≥2 ≤6 attacks/month Female subject childbearing potential must agree use acceptable birth control Have abdominal thigh injection site sufficient subcutaneous tissue needlefree injection Fluent speak write English language Provide write informed consent participate study willing comply study procedure Access telephone call center interactions A history , symptom , sign ischemic cardiac , cerebrovascular , peripheral vascular syndrome include ischemic vasospastic coronary artery disease Other significant underlie cardiovascular disease include uncontrolled hypertension Hemiplegic basilar migraine A history diagnosis severe hepatic renal impairment A history epilepsy seizure serious neurologic condition A history allergy , anaphylaxis , hypersensitivity sumatriptan component similar drug A history scleroderma ( systemic sclerosis ) skin condition may adversely affect injection absorption subcutaneously administer medication Tattoos thigh abdominal area large enough restrict injection site selection and/or evaluation Birthmark significant skin discoloration thigh abdominal area large enough restrict injection site selection and/or evaluation Pregnancy breastfeeding Have participate clinical trial receipt experimental therapy within 30 day prior dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>migraine</keyword>
	<keyword>sumatripatan</keyword>
</DOC>